Gerson Cancer Treatment

As the best source of information on the Gerson Therapy you are referred to The Gerson Institute Home Page.

 


Gerson Cancer Treatment can help with the following

Risks  


Tumors, Malignant  

Melanoma

The 5-year survival rates of patients using the Gerson Therapy reported in this study are considerably higher than those reported elsewhere. Stage IIIA/B males had exceptionally high survival rates compared with those reported by other centers.

Of 14 patients with stages I and II (localized) melanoma, 100% survived for 5 years, compared with 79% of 15,798 reported by Balch. Of 17 with stage IIIA (regionally metastasized) melanoma, 82% were alive at 5 years, in contrast to 39% of 103 from Fachklinik Hornheide. Of 33 with combined stages IIIA + IIIB (regionally metastasized) melanoma, 70% lived 5 years, compared with 41% of 134 from Fachklinik Hornheide. We propose a new stage division: IVA (distant lymph, skin, and subcutaneous tissue metastases), and IVB (visceral metastases). Of 18 with stage IVA melanoma, 39% were alive at 5 years, compared with only 6% of 194 from the Eastern Cooperative Oncology Group. Survival impact was not assessed for stage IVB. Male and female survival rates were identical for stages I-IIIB, but stage IVA women had a strong survival advantage. [Altern Ther Health Med 1995 Sep;1(4): pp.29-37]



 


Key

May do some good
Highly recommended

Leave a Reply

Your email address will not be published. Required fields are marked *